{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:12:26Z","timestamp":1793056346414,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"DOI":"10.1007\/s42000-026-00808-w","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:57:25Z","timestamp":1783965445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reproduction and fertility issues in women with congenital adrenal hyperplasia: pathophysiology, management, and recent clinical advances"],"prefix":"10.1007","author":[{"given":"\u0130nan","family":"Anaforo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-8709","authenticated-orcid":false,"given":"Melek Eda","family":"Ert\u00f6rer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"808_CR1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab016","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H et al (2022) Congenital adrenal hyperplasia\u2014current insights in pathophysiology, diagnostics, and management. Endocr Rev https:\/\/doi.org\/10.1210\/endrev\/bnab016","journal-title":"Endocr Rev"},{"key":"808_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01330-7","author":"MK Auer","year":"2023","unstructured":"Auer MK, Nordenstr\u00f6m A, Lajic S, Reisch N (2023) Congenital adrenal hyperplasia. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(22)01330-7","journal-title":"Lancet"},{"key":"808_CR3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01865","author":"PW Speiser","year":"2018","unstructured":"Speiser PW, Arlt W, Auchus RJ et al (2018) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2018-01865","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR4","doi-asserted-by":"publisher","unstructured":"Witchel SF (2017) Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol. 2017; 30(5): 520\u2013534. https:\/\/doi.org\/10.1016\/j.jpag.2017.04.001","DOI":"10.1016\/j.jpag.2017.04.001"},{"key":"808_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.06.025","author":"M Pall","year":"2010","unstructured":"Pall M, Azziz R, Beires J, Pignatelli D (2010) The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.06.025","journal-title":"Fertil Steril"},{"key":"808_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00388","author":"G Papadakis","year":"2019","unstructured":"Papadakis G, Kandaraki EA, Tseniklidi E, Papalou O, Diamanti-Kandarakis E (2019) Polycystic ovary syndrome and NC-CAH: distinct characteristics and common findings. A systematic review. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2019.00388","journal-title":"Front Endocrinol"},{"key":"808_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198701223160402","author":"RM Mulaikal","year":"1987","unstructured":"Mulaikal RM, Migeon CJ, Rock JA (1987) Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJM198701223160402","journal-title":"N Engl J Med"},{"key":"808_CR8","doi-asserted-by":"crossref","unstructured":"J\u00e4\u00e4skel\u00e4inen J, Hippel\u00e4inen M, Kiekara O, Voutilainen R (2000) Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency. Acta Obstet Gynecol Scand.","DOI":"10.1034\/j.1600-0412.2000.079008687.x"},{"key":"808_CR9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa801","author":"AL Hirschberg","year":"2021","unstructured":"Hirschberg AL, Gidl\u00f6f S, Falhammar H, Fris\u00e9n L, Almqvist C, Nordenskj\u00f6ld A et al (2021) Reproductive and perinatal outcomes in women with congenital adrenal hyperplasia: a population-based cohort study. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa801","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03563.x","author":"A Casteras","year":"2009","unstructured":"Casteras A, De Silva P, Rumsby G, Conway GS (2009) Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03563.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"808_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae211","author":"MK Auer","year":"2024","unstructured":"Auer MK, Minea CE, Quinkler M, Bancos I, Beuschlein F, Meyer G et al (2024) Women with congenital adrenal hyperplasia have favorable pregnancy outcomes but prolonged time to conceive. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvae211","journal-title":"J Endocr Soc"},{"key":"808_CR12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.74.3.1310999","author":"S Feldman","year":"1992","unstructured":"Feldman S, Billaud L, Thalabard JC, Raux-Demay MC, Mowszowicz I, Kuttenn F et al (1992) Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.74.3.1310999","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0062","author":"C Moran","year":"2006","unstructured":"Moran C, Azziz R, Weintrob N, Rohmer V, Dewailly D, Marcondes JAM et al (2006) Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2006-0062","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1383","author":"M Bidet","year":"2010","unstructured":"Bidet M, Bellan\u00e9e-Chantelot C, Galand-Portier MB, Golmard JL, Tardy V, Morel Y et al (2010) Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2009-1383","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14842","author":"C Carri\u00e8re","year":"2023","unstructured":"Carri\u00e8re C, Nguyen LS, Courtillot C et al (2023) Fertility and pregnancy outcomes in women with nonclassic 21-hydroxylase deficiency. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.14842","journal-title":"Clin Endocrinol (Oxf)"},{"key":"808_CR16","doi-asserted-by":"crossref","unstructured":"Anaforoglu I (2021) Mechanisms of reproductive dysfunction in classical and nonclassical congenital adrenal hyperplasia: from an endocrinologist\u2019s perspective. In: Ert\u00f6rer ME (ed) Fertility and Reproductive Outcomes in Different Forms of Congenital Adrenal Hyperplasia, 1st edn. Springer Nature, Cham, pp 63\u201391","DOI":"10.1007\/978-3-030-82591-1_5"},{"key":"808_CR17","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz142","author":"S van der Straaten","year":"2020","unstructured":"van der Straaten S, Springer A, Zecic A et al (2020) The external genitalia score (EGS): a European multicenter validation study. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz142","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1909786","author":"DP Merke","year":"2020","unstructured":"Merke DP, Auchus RJ (2020) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMra1909786","journal-title":"N Engl J Med"},{"key":"808_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.09.079","author":"NS Crouch","year":"2008","unstructured":"Crouch NS, Liao LM, Woodhouse CR, Conway GS, Creighton SM (2008) Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia. J Urol. https:\/\/doi.org\/10.1016\/j.juro.2007.09.079","journal-title":"J Urol"},{"key":"808_CR20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0556","author":"A Nordenskj\u00f6ld","year":"2008","unstructured":"Nordenskj\u00f6ld A, Holmdahl G, Fris\u00e9n L et al (2008) Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2007-0556","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0454","author":"A Bachelot","year":"2012","unstructured":"Bachelot A, Chakhtoura Z, Plu-Bureau G, Coudert M, Coussieu C, Badachi Y et al (2012) Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-12-0454","journal-title":"Eur J Endocrinol"},{"key":"808_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02034.x","author":"DJ Holmes-Walker","year":"1995","unstructured":"Holmes-Walker DJ, Conway GS, Honour JW, Rumsby G, Jacobs HS (1995) Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb02034.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"808_CR23","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.2.8636275","author":"L Ghizzoni","year":"1996","unstructured":"Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M et al (1996) Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.81.2.8636275","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.5.7962325","author":"RB Barnes","year":"1994","unstructured":"Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL et al (1994) Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.79.5.7962325","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1991.tb00235.x","author":"TD Pache","year":"1991","unstructured":"Pache TD, Chadha S, Gooren LJ, Hop WC, Jaarsma KW, Dommerholt HB et al (1991) Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology. https:\/\/doi.org\/10.1111\/j.1365-2559.1991.tb00235.x","journal-title":"Histopathology"},{"key":"808_CR26","unstructured":"Lucis OJ, Hobkirk R, Hollenberg CH, Macdonald SA, Blahey P (1966) Polycystic ovaries associated with congenital adrenal hyperplasia. Can Med Assoc J."},{"key":"808_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.06.026","author":"KA Walters","year":"2018","unstructured":"Walters KA, Handelsman DJ (2018) Role of androgens in the ovary. Mol Cell Endocrinol. https:\/\/doi.org\/10.1016\/j.mce.2017.06.026","journal-title":"Mol Cell Endocrinol"},{"key":"808_CR28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-2-378","author":"MR Soules","year":"1984","unstructured":"Soules MR, Steiner RA, Clifton DK, Cohen NL, Aksel S, Bremner WJ (1984) Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem-58-2-378","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der126","author":"E Labarta","year":"2011","unstructured":"Labarta E, Martinez-Conejero JA, Alama P, Horcajadas JA, Pellicer A, Sim\u00f3n C et al (2011) Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. https:\/\/doi.org\/10.1093\/humrep\/der126","journal-title":"Hum Reprod"},{"key":"808_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-016-9461-4","author":"HD Chen","year":"2017","unstructured":"Chen HD, Huang LE, Zhong ZH, Su Z, Jiang H, Zeng J (2017) Ovarian adrenal rest tumors undetected by imaging studies and identified at surgery in three females with congenital adrenal hyperplasia unresponsive to increased hormone therapy dosage. Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-016-9461-4","journal-title":"Endocr Pathol"},{"key":"808_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-014-0385-0","author":"V Pasterski","year":"2015","unstructured":"Pasterski V, Zucker KJ, Hindmarsh PC, Hughes IA, Acerini C, Spencer D et al (2015) Increased cross-gender identification independent of gender role behavior in girls with congenital adrenal hyperplasia: results from a standardized assessment of 4- to 11-year-old children. Arch Sex Behav. https:\/\/doi.org\/10.1007\/s10508-014-0385-0","journal-title":"Arch Sex Behav"},{"key":"808_CR32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0636","author":"L Fris\u00e9n","year":"2009","unstructured":"Fris\u00e9n L, Nordenstr\u00f6m A, Falhammar H, Filipsson H, Holmdahl G, Janson PO et al (2009) Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2009-0636","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0482-0","author":"AD Fisher","year":"2016","unstructured":"Fisher AD, Ristori J, Fanni E, Castellini G, Forti G, Maggi M (2016) Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major dilemma. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-016-0482-0","journal-title":"J Endocrinol Invest"},{"key":"808_CR34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1757","author":"F Gastaud","year":"2007","unstructured":"Gastaud F, Bouvattier C, Duranteau L, Brauner R, Thibaud E, Kutten F et al (2007) Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2006-1757","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01332-3","author":"A K\u0119pczy\u0144ska-Nyk","year":"2021","unstructured":"K\u0119pczy\u0144ska-Nyk A, Kury\u0142owicz A, Nowak A, Bednarczuk T, Ambroziak U (2021) Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01332-3","journal-title":"J Endocrinol Invest"},{"key":"808_CR36","doi-asserted-by":"publisher","unstructured":"Mouriquand PD, Gorduza DB, Gay CL, Meyer-Bahlburg HFL, Baker L, Baskin LS et al (2016) Surgery in disorders of sex development (DSD) with a gender issue: if (why), when, and how? J Pediatr Urol. 2016;12(3):139\u2013149. https:\/\/doi.org\/10.1016\/j.jpurol.2016.04.001","DOI":"10.1016\/j.jpurol.2016.04.001"},{"key":"808_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.03.021","author":"LC Wang","year":"2017","unstructured":"Wang LC, Poppas DP (2017) Surgical outcomes and complications of reconstructive surgery in the female congenital adrenal hyperplasia patient: what every endocrinologist should know. J Steroid Biochem Mol Biol. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"808_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09770-5","author":"JY Maher","year":"2023","unstructured":"Maher JY, Gomez-Lobo V, Merke DP (2023) The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum. Rev Endocr Metab Disord. https:\/\/doi.org\/10.1007\/s11154-022-09770-5","journal-title":"Rev Endocr Metab Disord"},{"key":"808_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206156","author":"G Cera","year":"2022","unstructured":"Cera G, Locantore P, Novizio R, Maggio E, Ramunno V, Corsello A et al (2022) Pregnancy and prenatal management of congenital adrenal hyperplasia. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11206156","journal-title":"J Clin Med"},{"key":"808_CR40","doi-asserted-by":"publisher","unstructured":"Simpson JL, Rechitsky S (2019) Prenatal genetic testing and treatment for congenital adrenal hyperplasia. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.11.041","DOI":"10.1016\/j.fertnstert.2018.11.041"},{"key":"808_CR41","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2005.06.004","author":"MI Evans","year":"2005","unstructured":"Evans MI, Wapner RJ (2005) Invasive prenatal diagnostic procedures. Semin Perinatol. https:\/\/doi.org\/10.1053\/j.semperi.2005.06.004","journal-title":"Semin Perinatol"},{"key":"808_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2011.01717.x","author":"CG Bauland","year":"2012","unstructured":"Bauland CG, Smit JM, Scheffers SM, Bartels RH, van den Berg P, Zee- bregts CJ, Spauwen PH (2012) Similar risk for hemangiomas after amniocentesis and transabdominal chorionic villus sampling. J Obstet Gynaecol Res. https:\/\/doi.org\/10.1111\/j.1447-0756.2011.01717.x","journal-title":"J Obstet Gynaecol Res"},{"key":"808_CR43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2895","author":"V Tardy-Guidollet","year":"2014","unstructured":"Tardy-Guidollet V, Menassa R, Costa JM, David M, Bouvattier-Morel C, Baumann C et al (2014) New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002\u20132011). J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2013-2895","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR44","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.7.7608248","author":"AB Mercado","year":"1995","unstructured":"Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI (1995) Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem.80.7.7608248","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR45","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0280","author":"T Hirvikoski","year":"2008","unstructured":"Hirvikoski T, Nordenstrom A, Lindholm T, Lindblad F, Ritzen EM, Lajic S (2008) Long-term follow-up of prenatally treated children at risk for congenital ad renal hyperplasia: does dexamethasone cause behavioural problems? Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-08-0280","journal-title":"Eur J Endocrinol"},{"key":"808_CR46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1340","author":"T Hirvikoski","year":"2007","unstructured":"Hirvikoski T, Nordenstrom A, Lindholm T, Lindblad F, Ritzen EM, Wedell A et al (2007) Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2006-1340","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1222","author":"T Hirvikoski","year":"2012","unstructured":"Hirvikoski T, Nordenstrom A, Wedell A, Ritzen M, Lajic S (2012) Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2012-1222","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR48","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199809000-00009","author":"G Celsi","year":"1998","unstructured":"Celsi G, Kistner A, Aizman R, Eklof AC, Ceccatelli S, deSantiago A et al (1998) Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res. https:\/\/doi.org\/10.1203\/00006450-199809000-00009","journal-title":"Pediatr Res"},{"key":"808_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61929-7","author":"KE Murphy","year":"2008","unstructured":"Murphy KE, Hannah ME, Willan AR, Hewson SA, Ohlsson A, Kelly EN et al (2008) Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(08)61929-7","journal-title":"Lancet"},{"key":"808_CR50","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3201","author":"RM Reynolds","year":"2012","unstructured":"Reynolds RM, Seekl JR (2012) Antenatal glucocorticoid treatment: are we doing harm to term babies? J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2012-3201","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR51","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.151u049","author":"JR Seekl","year":"2004","unstructured":"Seekl JR (2004) Prenatal glucocorticoids and long-term programming. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje.0.151u049","journal-title":"Eur J Endocrinol"},{"key":"808_CR52","doi-asserted-by":"publisher","unstructured":"Westeinde AV, Karlsson L, Messina V, Wallensteen L, Br\u00f6samle M, Maso GD et al (2023) An update on the long-term outcomes of prenatal dexamethasone treatment in CAH.\u00a0Endocr Connect.\u00a0https:\/\/doi.org\/10.1530\/EC-22-0400","DOI":"10.1530\/EC-22-0400"},{"key":"808_CR53","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0554","author":"H Nowotny","year":"2022","unstructured":"Nowotny H, Neumann U, Tardy-Guidollet V, Ahmed SF, Baronio F, Battelino T et al (2022) Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-21-0554","journal-title":"Eur J Endocrinol"},{"key":"808_CR54","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0395","author":"V Stachanow","year":"2021","unstructured":"Stachanow V, Neumann U, Blankenstein O, Fuhr U, Huisinga W, Michelet R et al (2021) Rationale of a lower dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-21-0395","journal-title":"Eur J Endocrinol"},{"key":"808_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf168.074","author":"O Dervishi","year":"2025","unstructured":"Dervishi O et al (2025) P29 - PREDICT \u2013 Clinical Trial on PREnatal Dexamethasone In Congenital adrenal hyperplasia Therapy. Eur J Endocrinol. https:\/\/doi.org\/10.1093\/ejendo\/lvaf168.074","journal-title":"Eur J Endocrinol"},{"key":"808_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05225.x","author":"S Nimkarn","year":"2010","unstructured":"Nimkarn S, New MI (2010) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann N Y Acad Sci. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05225.x","journal-title":"Ann N Y Acad Sci"},{"key":"808_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2010.06.007","author":"A Harris","year":"2011","unstructured":"Harris A, Seckl J (2011) Glucocorticoids, prenatal stress and the programming of disease. Horm Behav https:\/doi. https:\/\/doi.org\/10.1016\/j.yhbeh.2010.06.007","journal-title":"Horm Behav https:\/doi"},{"key":"808_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2019.05.011","author":"N Reisch","year":"2019","unstructured":"Reisch N (2019) Pregnancy in congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. https:\/\/doi.org\/10.1016\/j.ecl.2019.05.011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"808_CR59","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X19847832","author":"R Pofi","year":"2020","unstructured":"Pofi R, Tomlinson JW (2020) Glucocorticoids in pregnancy. Obstet Med. https:\/\/doi.org\/10.1177\/1753495X19847832","journal-title":"Obstet Med"},{"key":"808_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.05.004","author":"HC Claahsen-van der Grinten","year":"2011","unstructured":"Claahsen-van der Grinten HC, Stikkelbroeck N, Otten B, Hermus A (2011) Congenital adrenal hyperplasia\u2014pharmacologic interventions from the prenatal phase to adulthood. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.05.004","journal-title":"Pharmacol Ther"},{"key":"808_CR61","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab826","author":"MAM Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der MAM, van Herwaarden AE, Span PN, van den Akker ELT, Bocca G, Hannema SE et al (2022) Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgab826","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00217","author":"D MacKay","year":"2018","unstructured":"MacKay D, Nordenstr\u00f6m A, Falhammar H (2018) Bilateral adrenalectomy in congenital adrenal hyperplasia: a systematic review and meta-analysis. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2018-00217","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01863","author":"J Almasri","year":"2018","unstructured":"Almasri J, Zaiem F, Rodriguez-Gutierrez R, Tamhane SU, Iqbal AM, Prokop J et al (2018) Genital reconstructive surgery in females with congenital adrenal hyperplasia: a systematic review and meta-analysis. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2018-01863","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR64","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1233490","author":"LH Braga","year":"2009","unstructured":"Braga LH, Pippi Salle JL (2009) Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment. Eur J Pediatr Surg. https:\/\/doi.org\/10.1055\/s-0029-1233490","journal-title":"Eur J Pediatr Surg"},{"key":"808_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05343-0","author":"SM Creighton","year":"2001","unstructured":"Creighton SM, Minto CL, Steele SJ (2001) Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(01)05343-0","journal-title":"Lancet"},{"key":"808_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2018.03.020","author":"LE Jesus","year":"2018","unstructured":"Jesus LE (2018) Feminizing genitoplasties: where are we now? J Pediatr Urol. https:\/\/doi.org\/10.1016\/j.jpurol.2018.03.020","journal-title":"J Pediatr Urol"},{"key":"808_CR67","unstructured":"Birnbaum MD, Rose LI (1984) Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction. Obstet Gynecol."},{"key":"808_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-201298","author":"D Jain","year":"2013","unstructured":"Jain D (2013) Fertility and pregnancy outcome in a woman with classic congenital adrenal hyperplasia. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2013-201298","journal-title":"BMJ Case Rep"},{"key":"808_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2012.01903.x","author":"IN Purwana","year":"2013","unstructured":"Purwana IN, Kanasaki H, Oride A, Miyazaki K (2013) Successful pregnancy after the treatment of primary amenorrhea in a patient with non-classical congenital adrenal hyperplasia. J Obstet Gynaecol Res. https:\/\/doi.org\/10.1111\/j.1447-0756.2012.01903.x","journal-title":"J Obstet Gynaecol Res"},{"key":"808_CR70","doi-asserted-by":"publisher","DOI":"10.1159\/000292273","author":"C Laohaprasitiporn","year":"1996","unstructured":"Laohaprasitiporn C, Barbieri RL, Yeh J (1996) Induction of ovulation with the sole use of clomiphene citrate in late-onset 21-hydroxylase deficiency. Gynecol Obstet Invest. https:\/\/doi.org\/10.1159\/000292273","journal-title":"Gynecol Obstet Invest"},{"key":"808_CR71","doi-asserted-by":"publisher","DOI":"10.1055\/a-0893-3122","author":"S Jiang","year":"2019","unstructured":"Jiang S, Kuang Y (2019) Cycle characteristics and outcomes of infertile nonclassic 21-hydroxylase deficiency patients undergoing ovarian stimulation for in vitro fertilization. Horm Metab Res. https:\/\/doi.org\/10.1055\/a-0893-3122","journal-title":"Horm Metab Res"},{"key":"808_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13288","author":"Y Kawarai","year":"2017","unstructured":"Kawarai Y, Ishikawa H, Segawa T, Teramoto S, Tanaka T, Shozu M (2017) High serum progesterone associated with infertility in a woman with nonclassic congenital adrenal hyperplasia. J Obstet Gynaecol Res. https:\/\/doi.org\/10.1111\/jog.13288","journal-title":"J Obstet Gynaecol Res"},{"key":"808_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345586","author":"H Falhammar","year":"2008","unstructured":"Falhammar H, Thor\u00e9n M, Hagenfeldt K (2008) A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/BF03345586","journal-title":"J Endocrinol Invest"},{"key":"808_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.07.1103","author":"E Trakakis","year":"2011","unstructured":"Trakakis E, Dracopoulou-Vabouli M, Dacou-Voutetakis C, Basios G, Chrelias C, Kassanos D (2011) Infertility reversed by glucocorticoids and full-term pregnancy in a couple with previously undiagnosed nonclassic congenital adrenal hyperplasia. Fertil Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.07.1103","journal-title":"Fertil Steril"},{"key":"808_CR75","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa266","author":"C Bothou","year":"2020","unstructured":"Bothou C, Anand G, Li D, Kienitz T, Seejore K, Simeoli C et al (2020) Current management and outcome of pregnancies in women with adrenal insufficiency: experience from a multicenter survey. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa266","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR76","doi-asserted-by":"publisher","unstructured":"Auchus RJ, Hamidi O, Pivonello R, CAHtalyst Adult Trial Investigators et al (2024) Phase 3 trial of crinecerfont in adult congenital adrenal hyperplasia. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2404656","DOI":"10.1056\/NEJMoa2404656"},{"key":"808_CR77","doi-asserted-by":"publisher","unstructured":"Sarafoglou K, Kim MS, Lodish M et al (2024) Phase 3 trial of crinecerfont in pediatric congenital adrenal hyperplasia. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2404655. CAHtalyst Pediatric Trial Investigators","DOI":"10.1056\/NEJMoa2404655"},{"key":"808_CR78","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae759","author":"K Sarafoglou","year":"2025","unstructured":"Sarafoglou K, Auchus RJ (2025) Future directions in the management of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae759","journal-title":"J Clin Endocrinol Metab"},{"key":"808_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-025-01089-w","author":"H Falhammar","year":"2025","unstructured":"Falhammar H, Lajic S, Nordenstr\u00f6m A (2025) Recent advances in treatments for congenital adrenal hyperplasia. Nat Rev Endocrinol. https:\/\/doi.org\/10.1038\/s41574-025-01089-w","journal-title":"Nat Rev Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00808-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-026-00808-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00808-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:57:27Z","timestamp":1783965447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-026-00808-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":79,"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s42000-026-00808-w","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that the content of this article is compliant with ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The authors have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The authors used an artificial intelligence language model (Claude, Anthropic) to assist with language editing and improving the clarity and readability of the manuscript. All scientific content, interpretations, and conclusions were generated by the authors, who take full responsibility for the accuracy and integrity of the published work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of artificial intelligence"}}]}}